1,3-ditolylguanidine has been researched along with Dementia Praecox in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rückert, NG; Schmidt, WJ | 1 |
| Mori, H; Shibuya, H; Toru, M | 1 |
| Brown, JE; Middlemiss, DN; Reynolds, GP | 1 |
| Battaglia, G; De Souza, EB; Jaffe, JH; Kulsakdinun, C; Wolfe, SA | 1 |
4 other study(ies) available for 1,3-ditolylguanidine and Dementia Praecox
| Article | Year |
|---|---|
The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia.
Topics: Amphetamine; Animals; Behavior, Animal; Binding Sites; Dizocilpine Maleate; Guanidines; Male; Models, Biological; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, sigma; Schizophrenia | 1993 |
Sigma receptors in schizophrenic cerebral cortices.
Topics: Adult; Aged; Amino Acids; Animals; Cations; Cerebral Cortex; Female; Guanidines; Humans; Male; Middle Aged; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Schizophrenia | 1992 |
[3H]ditolylguanidine binding to human brain sigma sites is diminished after haloperidol treatment.
Topics: Binding Sites; Brain; Guanidines; Haloperidol; Humans; Schizophrenia; Tritium | 1991 |
Initial identification and characterization of sigma receptors on human peripheral blood leukocytes.
Topics: Animals; Guanidines; Haloperidol; Leukocytes; Lymphocyte Activation; Male; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma; Schizophrenia | 1988 |